Developer docs
API playgroundTry for free, no card

Search company profiles

Geneticancer

Full company profile

uuid004heuu

Namestring
Geneticancer
Legal namestring
GENETICANCER
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Geneticancer (stylized as GenetiCancer) is a French nonprofit association (Association Loi 1901) founded in 2016 and headquartered at 169 rue Lecourbe, 75015 Paris. It is dedicated to informing, supporting, and raising awareness about hereditary and genetic cancers, with a particular focus on carriers of BRCA1, BRCA2, TP53, PALB2, ATM, PTEN, and CDH1 mutations. The organization was established by Laetitia Mendes, a BRCA mutation carrier, and is led by her as President. Its operational backbone is a network of 106 volunteer ambassadors distributed across all French regions, providing localized peer support, alongside a scientific committee anchored by senior oncogeneticists including Pr Dominique Stoppa-Lyonnet of Institut Curie.

The association's product surface is built on a standard web stack: a WordPress website with WooCommerce for e-commerce, Stripe for payment processing, and integrations for YouTube, Wistia, Google Analytics, Google reCAPTCHA, and Complianz. Core offerings include three illustrated information brochures covering genetic testing, family communication, and risk-reducing surgeries; a genetic risk self-assessment questionnaire; an educational video series ("L'oncogénétique en 3 minutes"); a personal health companion tool called My Genetibook; a #mygeneticstory testimonial platform; and an e-shop selling solidarity merchandise such as books, teddy bears, tote-bags, caps, and gala tickets.

Geneticancer is primarily a donation-funded nonprofit. Its revenue model rests on three streams: tax-deductible individual donations (66% deduction up to 20% of taxable income for French taxpayers, enabled by its "Association d'intérêt général" status since September 2017), e-commerce sales of solidarity products, and recurring annual membership fees. The association also runs events — solidarity races, conferences, roundtables, galas — as both awareness and fundraising vehicles. A 2021 solidarity race mobilized over 1,100 participants and generated 6,800 euros, with 7,000 euros subsequently directed to the GENEPSO national research study. Distribution is omnichannel: the website and e-shop, an active Instagram presence, YouTube video content, email newsletters, regional ambassadors, in-person events, and earned media coverage across major French outlets including TF1, M6, France 2, BFM TV, RTL, and Europe 1, as well as women's press such as Gala, Elle, and Marie-Claire.

Short descriptiontext

Geneticancer is a French nonprofit association founded in 2016 that informs, supports, and accompanies individuals and families affected by hereditary cancers (BRCA1/2 and other predispositions) through a national network of 106 volunteer ambassadors, educational content, and research funding.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hereditary cancer prevention, oncogenetics patient support, cancer genetic association, BRCA mutation awareness, solidarity merchandise fundraising
Industry1 code
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
NAICS code1 code
  • Voluntary Health Organizations813212
SIC code1 code
  • Services-Educational Services8200
Product category
Nonprofit Cancer Advocacy Services
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Donations
TypeGrants Donations
Description

The association receives donations from the public, which are tax-deductible at 66% up to 20% of taxable income for French taxpayers. Donations fund research, prevention actions, and patient/family support.

geneticancer.org
2E-commerce Sales
TypeHardware Sales
Description

Sale of solidarity products including the book by Laetitia Mendes, teddys (adults and children), tote-bags, caps, and gala tickets. These goods are marketed to finance genetic cancer research projects.

geneticancer.org
3Membership Adhesions
TypeSubscription Recurring
Description

Annual membership fees for supporters wishing to join the association and contribute to its mission.

geneticancer.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Solidarity products including teddys (adults and children), tote-bags, caps, and books
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Various solidarity products sold at different price points; specific prices not publicly disclosed on the website

geneticancer.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Geneticancer is a French nonprofit association (Loi 1901) that informs, supports, and raises awareness about genetic and hereditary cancers. It delivers educational resources (brochures, videos, self-assessment questionnaires), a personal health companion tool (My Genetibook), a nationwide network of 106 regional volunteer ambassadors, and funds genetic cancer research. The association also sells solidarity merchandise and accepts tax-deductible donations to support its mission.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Supported thousands of families across France with genetic cancer risk
+2 more records
Product overview1 text field

Geneticancer is a non-profit association (Loi 1901) focused on preventing genetic and hereditary cancers. The organization offers a combination of information resources (brochures, videos, self-assessment questionnaires), digital tools (My Genetibook), an e-commerce platform for solidarity merchandise, and donation/membership services. Core offerings include educational content explaining oncogenetics, a network of regional ambassadors providing support, and funding for research projects. The association's digital ecosystem is built on WordPress with WooCommerce for e-commerce and Stripe for secure payment processing.

Product and service1 record
1My Genetibook
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-21
Description

Partnership for the May 2025 conference on genetic cancers in Lyon, bringing together healthcare professionals, patients, and relatives for two roundtables on genetic testing communication and prevention.

2Syndrome de Lynch France
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-21
Description

Co-organization of the May 2025 Lyon conference on genetic cancers, specifically addressing Lynch syndrome alongside BRCA and other hereditary cancer syndromes.

geneticancer.org
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-09-14
Description

Pharmaceutical laboratory collaborated with IMAGYN (association of gynecological cancer patients) to publish a booklet on PARP inhibitor treatments for ovarian cancer patients.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-09-14
Description

Association of gynecological cancer patients collaborated with Clovis Oncology to create educational materials on PARP inhibitors for ovarian cancer care.

5Pr Dominique Stoppa-Lyonnet (Institut Curie, Paris)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-05-20
Description

Head of oncogenetics department at Institut Curie, member of Geneticancer's scientific council providing research expertise.

geneticancer.org
6GENEPSO (Gène Étude Prospective Sein Ovaire)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-04-18
Description

National research study directed by Dr. Catherine Noguès since 1999, aiming to identify modifying factors for breast and ovarian cancer risks in BRCA1/BRCA2 mutation carriers. Geneticancer contributed 7,000 euros to support this research.

geneticancer.org
7Pr Pierre Pujol (CHRU de Montpellier)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-03-15
Description

Oncogeneticist at CHU Montpellier quoted regarding new European recommendations for expanded BRCA1/2 testing eligibility.

geneticancer.org
Strategic tierCoreTypeOthersAnnounced on2017-09-12
Description

Official recognition as 'Association d'intérêt général à caractère social' under articles 200 and 238 bis of the French General Tax Code, enabling tax-deductible donations.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Geneticancer

Nonprofit Cancer Advocacy Servicesgeneticancer.org

Geneticancer is a French nonprofit association founded in 2016 that informs, supports, and accompanies individuals and families affected by hereditary cancers (BRCA1/2 and other predispositions) through a national network of 106 volunteer ambassadors, educational content, and research funding.

What Geneticancer does

Geneticancer (stylized as GenetiCancer) is a French nonprofit association (Association Loi 1901) founded in 2016 and headquartered at 169 rue Lecourbe, 75015 Paris. It is dedicated to informing, supporting, and raising awareness about hereditary and genetic cancers, with a particular focus on carriers of BRCA1, BRCA2, TP53, PALB2, ATM, PTEN, and CDH1 mutations. The organization was established by Laetitia Mendes, a BRCA mutation carrier, and is led by her as President. Its operational backbone is a network of 106 volunteer ambassadors distributed across all French regions, providing localized peer support, alongside a scientific committee anchored by senior oncogeneticists including Pr Dominique Stoppa-Lyonnet of Institut Curie.

The association's product surface is built on a standard web stack: a WordPress website with WooCommerce for e-commerce, Stripe for payment processing, and integrations for YouTube, Wistia, Google Analytics, Google reCAPTCHA, and Complianz. Core offerings include three illustrated information brochures covering genetic testing, family communication, and risk-reducing surgeries; a genetic risk self-assessment questionnaire; an educational video series ("L'oncogénétique en 3 minutes"); a personal health companion tool called My Genetibook; a #mygeneticstory testimonial platform; and an e-shop selling solidarity merchandise such as books, teddy bears, tote-bags, caps, and gala tickets.

Geneticancer is primarily a donation-funded nonprofit. Its revenue model rests on three streams: tax-deductible individual donations (66% deduction up to 20% of taxable income for French taxpayers, enabled by its "Association d'intérêt général" status since September 2017), e-commerce sales of solidarity products, and recurring annual membership fees. The association also runs events — solidarity races, conferences, roundtables, galas — as both awareness and fundraising vehicles. A 2021 solidarity race mobilized over 1,100 participants and generated 6,800 euros, with 7,000 euros subsequently directed to the GENEPSO national research study. Distribution is omnichannel: the website and e-shop, an active Instagram presence, YouTube video content, email newsletters, regional ambassadors, in-person events, and earned media coverage across major French outlets including TF1, M6, France 2, BFM TV, RTL, and Europe 1, as well as women's press such as Gala, Elle, and Marie-Claire.

Geneticancer firmographics

Firmographics
Name
Geneticancer
Legal name
GENETICANCER
Website
https://geneticancer.org
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Geneticancer is a French nonprofit association founded in 2016 that informs, supports, and accompanies individuals and families affected by hereditary cancers (BRCA1/2 and other predispositions) through a national network of 106 volunteer ambassadors, educational content, and research funding.
Ownership category
akta.pro rank

Where Geneticancer is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Geneticancer business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Donations: The association receives donations from the public, which are tax-deductible at 66% up to 20% of taxable income for French taxpayers. Donations fund research, prevention actions, and patient/family support.
  2. E-commerce Sales: Sale of solidarity products including the book by Laetitia Mendes, teddys (adults and children), tote-bags, caps, and gala tickets. These goods are marketed to finance genetic cancer research projects.
  3. Membership Adhesions: Annual membership fees for supporters wishing to join the association and contribute to its mission.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goSolidarity products including teddys (adults and children), tote-bags, caps, and books

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Geneticancer product offering

Product offering

Core offering

Geneticancer is a French nonprofit association (Loi 1901) that informs, supports, and raises awareness about genetic and hereditary cancers. It delivers educational resources (brochures, videos, self-assessment questionnaires), a personal health companion tool (My Genetibook), a nationwide network of 106 regional volunteer ambassadors, and funds genetic cancer research. The association also sells solidarity merchandise and accepts tax-deductible donations to support its mission.

Product overview

Geneticancer is a non-profit association (Loi 1901) focused on preventing genetic and hereditary cancers. The organization offers a combination of information resources (brochures, videos, self-assessment questionnaires), digital tools (My Genetibook), an e-commerce platform for solidarity merchandise, and donation/membership services. Core offerings include educational content explaining oncogenetics, a network of regional ambassadors providing support, and funding for research projects. The association's digital ecosystem is built on WordPress with WooCommerce for e-commerce and Stripe for secure payment processing.

Differentiator

Problem solved

Functional benefit

Products and services

  • My Genetibook

Quantifiable outcome

  • Supported thousands of families across France with genetic cancer risk
  • +2 more outcomes

Companies that use Geneticancer

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Geneticancer technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

Geneticancer partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Comité du Rhône de La Ligue contre le cancercoreStrategic or Co-development Partner · 21 May 2025Partnership for the May 2025 conference on genetic cancers in Lyon, bringing together healthcare professionals, patients, and relatives for two roundtables on genetic testing communication and prevention.
  • Syndrome de Lynch FrancecoreStrategic or Co-development Partner · 21 May 2025Co-organization of the May 2025 Lyon conference on genetic cancers, specifically addressing Lynch syndrome alongside BRCA and other hereditary cancer syndromes.
  • Clovis OncologyminorStrategic or Co-development Partner · 14 September 2021Pharmaceutical laboratory collaborated with IMAGYN (association of gynecological cancer patients) to publish a booklet on PARP inhibitor treatments for ovarian cancer patients.
  • IMAGYN (Association de patientes atteintes de cancers gynécologiques)minorStrategic or Co-development Partner · 14 September 2021Association of gynecological cancer patients collaborated with Clovis Oncology to create educational materials on PARP inhibitors for ovarian cancer care.
  • Pr Dominique Stoppa-Lyonnet (Institut Curie, Paris)minorStrategic or Co-development Partner · 20 May 2021Head of oncogenetics department at Institut Curie, member of Geneticancer's scientific council providing research expertise.
  • GENEPSO (Gène Étude Prospective Sein Ovaire)coreStrategic or Co-development Partner · 18 April 2021National research study directed by Dr. Catherine Noguès since 1999, aiming to identify modifying factors for breast and ovarian cancer risks in BRCA1/BRCA2 mutation carriers. Geneticancer contributed 7,000 euros to support this research.
  • Pr Pierre Pujol (CHRU de Montpellier)minorStrategic or Co-development Partner · 15 March 2021Oncogeneticist at CHU Montpellier quoted regarding new European recommendations for expanded BRCA1/2 testing eligibility.
  • French Tax Authority (DGFiP)coreOthers · 12 September 2017Official recognition as 'Association d'intérêt général à caractère social' under articles 200 and 238 bis of the French General Tax Code, enabling tax-deductible donations.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Geneticancer competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Geneticancer social profiles

Digital presence

Geneticancer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Geneticancer leadership team

Management profile

Number of profiles

Profiles2 records

Geneticancer funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Geneticancer M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Geneticancer

What does Geneticancer do?

Geneticancer is a French nonprofit association (Loi 1901) that informs, supports, and raises awareness about genetic and hereditary cancers. It delivers educational resources (brochures, videos, self-assessment questionnaires), a personal health companion tool (My Genetibook), a nationwide network of 106 regional volunteer ambassadors, and funds genetic cancer research. The association also sells solidarity merchandise and accepts tax-deductible donations to support its mission.

Is Geneticancer a public or private company?

Geneticancer is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Geneticancer founded?

Geneticancer was founded in 2016. It employs 1 to 10 people.

Where is Geneticancer based?

Geneticancer is headquartered in Paris, France, in the Europe region.

How does Geneticancer make money?

Three revenue lines are on record. Donations are the primary driver. The others are E-commerce Sales and membership Adhesions.

Does Geneticancer have an API?

No public API is recorded for Geneticancer.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales